메뉴 건너뛰기




Volumn 100, Issue 3, 2011, Pages 148-156

Rebound acid hypersecretion after withdrawal of gastric acid suppressing drugs: New evidence of similitude

Author keywords

Homeopathy; Paradoxical reaction; Proton pump inhibitor; Rebound effect; Secondary effect; Similitude; Withdrawal syndrome

Indexed keywords

ESOMEPRAZOLE; GASTROINTESTINAL AGENT; PANTOPRAZOLE; PENTAGASTRIN; PROTON PUMP INHIBITOR; RANITIDINE;

EID: 79960625946     PISSN: 14754916     EISSN: 14764245     Source Type: Journal    
DOI: 10.1016/j.homp.2011.05.003     Document Type: Article
Times cited : (19)

References (120)
  • 1
    • 79960626034 scopus 로고
    • Essay on a new principle for ascertaining the curative power of drugs, with a few glances at those hitherto employed
    • B. Jain Publishers, New Delhi, R.E. Dudgeon (Ed.)
    • Hahnemann S. Essay on a new principle for ascertaining the curative power of drugs, with a few glances at those hitherto employed. The lesser writings of Samuel Hahnemann 1995, B. Jain Publishers, New Delhi. R.E. Dudgeon (Ed.).
    • (1995) The lesser writings of Samuel Hahnemann
    • Hahnemann, S.1
  • 2
    • 34147117160 scopus 로고
    • Third American edition. English version of the fifth German edition, William Radde, New York
    • Hahnemann S. Organ on of homeopathic medicine 1849, Third American edition. English version of the fifth German edition, William Radde, New York.
    • (1849) Organ on of homeopathic medicine
    • Hahnemann, S.1
  • 3
    • 0004063374 scopus 로고
    • (Translated by William Boericke), B Jain Publishers, New Delhi
    • Hahnemann S. Organon of medicine 1991, (Translated by William Boericke), B Jain Publishers, New Delhi. 6th edn.
    • (1991) Organon of medicine
    • Hahnemann, S.1
  • 5
    • 0343709172 scopus 로고
    • B Jain Publishers, New Delhi, (Second reprint edition). Lecture II
    • Hughes R. A manual of pharmacodynamics 1980, B Jain Publishers, New Delhi, (Second reprint edition). Lecture II. 6th edn.
    • (1980) A manual of pharmacodynamics
    • Hughes, R.1
  • 7
    • 0032802653 scopus 로고    scopus 로고
    • Similitude in modern pharmacology
    • Teixeira M.Z. Similitude in modern pharmacology. Homeopathy 1999, 88(3):112-120.
    • (1999) Homeopathy , vol.88 , Issue.3 , pp. 112-120
    • Teixeira, M.Z.1
  • 8
    • 33749047860 scopus 로고    scopus 로고
    • Evidence of the principle of similitude in modern fatal iatrogenic events
    • Teixeira M.Z. Evidence of the principle of similitude in modern fatal iatrogenic events. Homeopathy 2006, 95(4):229-236.
    • (2006) Homeopathy , vol.95 , Issue.4 , pp. 229-236
    • Teixeira, M.Z.1
  • 9
    • 33846148713 scopus 로고    scopus 로고
    • NSAIDs, myocardial infarction, rebound effect and similitude
    • Teixeira M.Z. NSAIDs, myocardial infarction, rebound effect and similitude. Homeopathy 2007, 96(1):67-68.
    • (2007) Homeopathy , vol.96 , Issue.1 , pp. 67-68
    • Teixeira, M.Z.1
  • 10
    • 34147152787 scopus 로고    scopus 로고
    • Bronchodilators, fatal asthma, rebound effect and similitude
    • Teixeira M.Z. Bronchodilators, fatal asthma, rebound effect and similitude. Homeopathy 2007, 96(2):135-137.
    • (2007) Homeopathy , vol.96 , Issue.2 , pp. 135-137
    • Teixeira, M.Z.1
  • 11
    • 63549113234 scopus 로고    scopus 로고
    • Antidepressants, suicidality and rebound effect: evidence of similitude?
    • Teixeira M.Z. Antidepressants, suicidality and rebound effect: evidence of similitude?. Homeopathy 2009, 98(1):114-121.
    • (2009) Homeopathy , vol.98 , Issue.1 , pp. 114-121
    • Teixeira, M.Z.1
  • 12
    • 77958115678 scopus 로고    scopus 로고
    • Statins withdrawal, vascular complications, rebound effect and similitude
    • Teixeira M.Z. Statins withdrawal, vascular complications, rebound effect and similitude. Homeopathy 2010, 99(4):255-262.
    • (2010) Homeopathy , vol.99 , Issue.4 , pp. 255-262
    • Teixeira, M.Z.1
  • 16
    • 0034954607 scopus 로고    scopus 로고
    • Problems related to acid rebound and tachyphylaxis
    • Gillen D., McColl K.E. Problems related to acid rebound and tachyphylaxis. Best Pract Res Clin Gastroenterol 2001, 15(3):487-495.
    • (2001) Best Pract Res Clin Gastroenterol , vol.15 , Issue.3 , pp. 487-495
    • Gillen, D.1    McColl, K.E.2
  • 17
    • 0035654604 scopus 로고    scopus 로고
    • Problems associated with the clinical use of proton pump inhibitors
    • Gillen D., McColl K.E. Problems associated with the clinical use of proton pump inhibitors. Pharmacol Toxicol 2001, 89(6):281-286.
    • (2001) Pharmacol Toxicol , vol.89 , Issue.6 , pp. 281-286
    • Gillen, D.1    McColl, K.E.2
  • 18
    • 77949910670 scopus 로고    scopus 로고
    • Rebound acid hypersecretion from a physiological, pathophysiological and clinical viewpoint
    • Waldum H.L., Qvigstad G., Fossmark R., Kleveland P.M., Sandvik A.K. Rebound acid hypersecretion from a physiological, pathophysiological and clinical viewpoint. Scand J Gastroenterol 2010, 45(4):389-394.
    • (2010) Scand J Gastroenterol , vol.45 , Issue.4 , pp. 389-394
    • Waldum, H.L.1    Qvigstad, G.2    Fossmark, R.3    Kleveland, P.M.4    Sandvik, A.K.5
  • 20
    • 0024556539 scopus 로고
    • A critical look at the clinical use of antacids in acid-peptic disease and gastric acid rebound
    • Texter E.C. A critical look at the clinical use of antacids in acid-peptic disease and gastric acid rebound. Am J Gastroenterol 1989, 84(2):97-108.
    • (1989) Am J Gastroenterol , vol.84 , Issue.2 , pp. 97-108
    • Texter, E.C.1
  • 21
    • 0026652516 scopus 로고
    • Calcium and acid rebound: a reappraisal
    • Hade J.E., Spiro H.M. Calcium and acid rebound: a reappraisal. J Clin Gastroenterol 1992, 15(1):37-44.
    • (1992) J Clin Gastroenterol , vol.15 , Issue.1 , pp. 37-44
    • Hade, J.E.1    Spiro, H.M.2
  • 22
    • 0002859367 scopus 로고
    • Effects of aluminum/magnesium hydroxide and calcium carbonate on esophageal and gastric pH in subjects with heartburn
    • Decktor D.L., Robinson M., Maton P.N., Lanza F.L., Gottlieb S. Effects of aluminum/magnesium hydroxide and calcium carbonate on esophageal and gastric pH in subjects with heartburn. Am J Ther 1995, 2(8):546-552.
    • (1995) Am J Ther , vol.2 , Issue.8 , pp. 546-552
    • Decktor, D.L.1    Robinson, M.2    Maton, P.N.3    Lanza, F.L.4    Gottlieb, S.5
  • 23
    • 0028857146 scopus 로고
    • Gastric emptying of two radiolabelled antacids with simultaneous monitoring of gastric pH
    • Monés J., Carrio I., Sainz S., et al. Gastric emptying of two radiolabelled antacids with simultaneous monitoring of gastric pH. Eur J Nucl Med 1995, 22(10):1123-1128.
    • (1995) Eur J Nucl Med , vol.22 , Issue.10 , pp. 1123-1128
    • Monés, J.1    Carrio, I.2    Sainz, S.3
  • 24
    • 0029882747 scopus 로고    scopus 로고
    • Effect of Rennie Liquid versus Maalox Liquid on intragastric ph in a double-blind, randomized, placebo-controlled, triple cross-over study in healthy volunteers
    • Hürlimann S., Michel K., Inauen W., Halter F. Effect of Rennie Liquid versus Maalox Liquid on intragastric ph in a double-blind, randomized, placebo-controlled, triple cross-over study in healthy volunteers. Am J Gastroenterol 1996, 91(6):1173-1180.
    • (1996) Am J Gastroenterol , vol.91 , Issue.6 , pp. 1173-1180
    • Hürlimann, S.1    Michel, K.2    Inauen, W.3    Halter, F.4
  • 25
    • 0030485247 scopus 로고    scopus 로고
    • Absence of rebound effect with calcium carbonate
    • Simoneau G. Absence of rebound effect with calcium carbonate. Eur J Drug Metab Pharmacokinet 1996, 21(4):351-357.
    • (1996) Eur J Drug Metab Pharmacokinet , vol.21 , Issue.4 , pp. 351-357
    • Simoneau, G.1
  • 26
    • 0018347063 scopus 로고
    • Parietal and chief cell sensitivity to pentagastrin stimulation before and after cimetidine treatment for duodenal ulcer
    • Aadland E., Berstad A. Parietal and chief cell sensitivity to pentagastrin stimulation before and after cimetidine treatment for duodenal ulcer. Scand J Gastroenterol 1979, 14(1):111-114.
    • (1979) Scand J Gastroenterol , vol.14 , Issue.1 , pp. 111-114
    • Aadland, E.1    Berstad, A.2
  • 27
    • 0020458023 scopus 로고
    • Bombesin: action on gut hormones and calcium in man
    • Ghatei M.A., Jung R.T., Stevenson J.C., et al. Bombesin: action on gut hormones and calcium in man. J Clin Endocrinol Metab 1982, 54(5):980-985.
    • (1982) J Clin Endocrinol Metab , vol.54 , Issue.5 , pp. 980-985
    • Ghatei, M.A.1    Jung, R.T.2    Stevenson, J.C.3
  • 28
    • 0023819696 scopus 로고
    • Alteration of H2 receptor sensitivity in duodenal ulcer patients after maintenance treatment with an H2 receptor antagonist
    • Jones D.B., Howden C.W., Burget D.W., Silletti C., Hunt R.H. Alteration of H2 receptor sensitivity in duodenal ulcer patients after maintenance treatment with an H2 receptor antagonist. Gut 1988, 29(7):890-893.
    • (1988) Gut , vol.29 , Issue.7 , pp. 890-893
    • Jones, D.B.1    Howden, C.W.2    Burget, D.W.3    Silletti, C.4    Hunt, R.H.5
  • 30
    • 0017849120 scopus 로고
    • Maintenance treatment of recurrent peptic ulcer by cimetidine
    • Bodemar G., Walan A. Maintenance treatment of recurrent peptic ulcer by cimetidine. Lancet 1978, 1(8061):403-407.
    • (1978) Lancet , vol.1 , Issue.8061 , pp. 403-407
    • Bodemar, G.1    Walan, A.2
  • 31
    • 0018353183 scopus 로고
    • Effect of long-term cimetidine on gastric acid secretion, serum gastrin, and gastric emptying
    • Forrest J.A., Fettes M.R., McLoughlin G.P., Heading R.C. Effect of long-term cimetidine on gastric acid secretion, serum gastrin, and gastric emptying. Gut 1979, 20(5):404-407.
    • (1979) Gut , vol.20 , Issue.5 , pp. 404-407
    • Forrest, J.A.1    Fettes, M.R.2    McLoughlin, G.P.3    Heading, R.C.4
  • 32
    • 0019156148 scopus 로고
    • Effect of treatment with cimetidine for one year on gastrin cell and parietal cell function and sensitivity to cimetidine in patients with duodenal or gastric ulcers
    • Festen H.P., Lamers C.B., Tangerman A., van Tongeren J.H. Effect of treatment with cimetidine for one year on gastrin cell and parietal cell function and sensitivity to cimetidine in patients with duodenal or gastric ulcers. Postgrad Med J 1980, 56(660):698-701.
    • (1980) Postgrad Med J , vol.56 , Issue.660 , pp. 698-701
    • Festen, H.P.1    Lamers, C.B.2    Tangerman, A.3    van Tongeren, J.H.4
  • 33
    • 0020680959 scopus 로고
    • Effects of eight weeks' continuous treatment with oral ranitidine and cimetidine on gastric acid secretion, pepsin secretion, and fasting serum gastrin
    • Mohammed R., Holden R.J., Hearns J.B., McKibben B.M., Buchanan K.D., Crean G.P. Effects of eight weeks' continuous treatment with oral ranitidine and cimetidine on gastric acid secretion, pepsin secretion, and fasting serum gastrin. Gut 1983, 24(1):61-66.
    • (1983) Gut , vol.24 , Issue.1 , pp. 61-66
    • Mohammed, R.1    Holden, R.J.2    Hearns, J.B.3    McKibben, B.M.4    Buchanan, K.D.5    Crean, G.P.6
  • 34
    • 0022631478 scopus 로고
    • Augmented postprandial gastric acid secretion due to exposure to ranitidine in healthy subjects
    • Frislid K., Aadland E., Berstad A. Augmented postprandial gastric acid secretion due to exposure to ranitidine in healthy subjects. Scand J Gastroenterol 1986, 21(1):119-122.
    • (1986) Scand J Gastroenterol , vol.21 , Issue.1 , pp. 119-122
    • Frislid, K.1    Aadland, E.2    Berstad, A.3
  • 35
    • 0024566540 scopus 로고
    • Rebound nocturnal hypersecretion after four weeks treatment with an H2 receptor antagonist
    • Fullarton G.M., McLauchlan G., Macdonald A., Crean G.P., McColl K.E. Rebound nocturnal hypersecretion after four weeks treatment with an H2 receptor antagonist. Gut 1989, 30(4):449-454.
    • (1989) Gut , vol.30 , Issue.4 , pp. 449-454
    • Fullarton, G.M.1    McLauchlan, G.2    Macdonald, A.3    Crean, G.P.4    McColl, K.E.5
  • 36
    • 0025918016 scopus 로고
    • Rebound hypersecretion after H2-antagonist withdrawal - a comparative study with nizatidine, ranitidine and famotidine
    • Fullarton G.M., Macdonald A.M., McColl K.E. Rebound hypersecretion after H2-antagonist withdrawal - a comparative study with nizatidine, ranitidine and famotidine. Aliment Pharmacol Ther 1991, 5(4):391-398.
    • (1991) Aliment Pharmacol Ther , vol.5 , Issue.4 , pp. 391-398
    • Fullarton, G.M.1    Macdonald, A.M.2    McColl, K.E.3
  • 37
    • 0025788327 scopus 로고
    • Rebound intragastric hyperacidity after abrupt withdrawal of histamine H2 receptor blockade
    • Nwokolo C.U., Smith J.T., Sawyerr A.M., Pounder R.E. Rebound intragastric hyperacidity after abrupt withdrawal of histamine H2 receptor blockade. Gut 1991, 32(12):1455-1460.
    • (1991) Gut , vol.32 , Issue.12 , pp. 1455-1460
    • Nwokolo, C.U.1    Smith, J.T.2    Sawyerr, A.M.3    Pounder, R.E.4
  • 38
    • 0026541912 scopus 로고
    • Changes in nocturnal and peak acid outputs after duodenal ulcer healing with sucralfate or ranitidine
    • Kummer A.F., Johnston D.A., Marks I.N., Young G.O., Tigler-Wybrandi N.A., Bridger S.A. Changes in nocturnal and peak acid outputs after duodenal ulcer healing with sucralfate or ranitidine. Gut 1992, 33(2):175-178.
    • (1992) Gut , vol.33 , Issue.2 , pp. 175-178
    • Kummer, A.F.1    Johnston, D.A.2    Marks, I.N.3    Young, G.O.4    Tigler-Wybrandi, N.A.5    Bridger, S.A.6
  • 39
    • 0033135961 scopus 로고    scopus 로고
    • Dyspepsia on withdrawal of ranitidine in previously asymptomatic volunteers
    • Smith A.D., Gillen D., Cochran K.M., El-Omar E., McColl K.E. Dyspepsia on withdrawal of ranitidine in previously asymptomatic volunteers. Am J Gastroenterol 1999, 94(5):1209-1213.
    • (1999) Am J Gastroenterol , vol.94 , Issue.5 , pp. 1209-1213
    • Smith, A.D.1    Gillen, D.2    Cochran, K.M.3    El-Omar, E.4    McColl, K.E.5
  • 40
  • 42
    • 0025005069 scopus 로고
    • Loss of acid suppression during dosing with H2-receptor antagonists
    • Wilder-Smith C., Halter F., Ernst T., et al. Loss of acid suppression during dosing with H2-receptor antagonists. Aliment Pharmacol Ther 1990, 4(Suppl. 1):15-27.
    • (1990) Aliment Pharmacol Ther , vol.4 , Issue.SUPPL. 1 , pp. 15-27
    • Wilder-Smith, C.1    Halter, F.2    Ernst, T.3
  • 43
    • 0025146273 scopus 로고
    • Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine
    • Nwokolo C.U., Smith J.T., Gavey C., Sawyerr A., Pounder R.E. Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine. Aliment Pharmacol Ther 1990, 4(Suppl. 1):29-45.
    • (1990) Aliment Pharmacol Ther , vol.4 , Issue.SUPPL. 1 , pp. 29-45
    • Nwokolo, C.U.1    Smith, J.T.2    Gavey, C.3    Sawyerr, A.4    Pounder, R.E.5
  • 44
    • 0025090936 scopus 로고
    • Tolerance during 8 days of high-dose H2-blockade: placebo-controlled studies of 24-hour acidity and gastrin
    • Smith J.T., Gavey C., Nwokolo C.U., Pounder R.E. Tolerance during 8 days of high-dose H2-blockade: placebo-controlled studies of 24-hour acidity and gastrin. Aliment Pharmacol Ther 1990, 4(Suppl. 1):47-63.
    • (1990) Aliment Pharmacol Ther , vol.4 , Issue.SUPPL. 1 , pp. 47-63
    • Smith, J.T.1    Gavey, C.2    Nwokolo, C.U.3    Pounder, R.E.4
  • 45
    • 0025076122 scopus 로고
    • The effects of 15 days of dosing with placebo, sufotidine 600 mg nocte or sufotidine 600 mg twice daily upon 24-hour intragastric acidity and 24-hour plasma gastrin
    • Rogers M.J., Holmfield J.H., Primrose J.N., Johnston D. The effects of 15 days of dosing with placebo, sufotidine 600 mg nocte or sufotidine 600 mg twice daily upon 24-hour intragastric acidity and 24-hour plasma gastrin. Aliment Pharmacol Ther 1990, 4(Suppl. 1):65-74.
    • (1990) Aliment Pharmacol Ther , vol.4 , Issue.SUPPL. 1 , pp. 65-74
    • Rogers, M.J.1    Holmfield, J.H.2    Primrose, J.N.3    Johnston, D.4
  • 46
    • 0026050512 scopus 로고
    • Tolerance during 5 months of dosing with ranitidine, 150 mg nightly: a placebo-controlled, double-blind study
    • Nwokolo C.U., Prewett E.J., Sawyerr A.M., Hudson M., Lim S., Pounder R.E. Tolerance during 5 months of dosing with ranitidine, 150 mg nightly: a placebo-controlled, double-blind study. Gastroenterology 1991, 101(4):948-953.
    • (1991) Gastroenterology , vol.101 , Issue.4 , pp. 948-953
    • Nwokolo, C.U.1    Prewett, E.J.2    Sawyerr, A.M.3    Hudson, M.4    Lim, S.5    Pounder, R.E.6
  • 47
    • 0028107146 scopus 로고
    • Do continuous infusions of omeprazole and ranitidine retain their effect with prolonged dosing?
    • Merki H.S., Wilder-Smith C.H. Do continuous infusions of omeprazole and ranitidine retain their effect with prolonged dosing?. Gastroenterology 1994, 106(1):60-64.
    • (1994) Gastroenterology , vol.106 , Issue.1 , pp. 60-64
    • Merki, H.S.1    Wilder-Smith, C.H.2
  • 48
    • 0025076123 scopus 로고
    • Clinical relevance of tolerance to peptic ulcer healing and relapse
    • Misiewicz J.J. Clinical relevance of tolerance to peptic ulcer healing and relapse. Aliment Pharmacol Ther 1990, 4(Suppl. 1):85-96.
    • (1990) Aliment Pharmacol Ther , vol.4 , Issue.SUPPL. 1 , pp. 85-96
    • Misiewicz, J.J.1
  • 49
    • 0026172834 scopus 로고
    • Much ado about gastrin
    • McQuaid K.R. Much ado about gastrin. J Clin Gastroenterol 1991, 13(3):249-254.
    • (1991) J Clin Gastroenterol , vol.13 , Issue.3 , pp. 249-254
    • McQuaid, K.R.1
  • 50
    • 0017927834 scopus 로고
    • Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage
    • Green F.W., Kaplan M.M., Curtis L.E., Levine P.H. Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage. Gastroenterology 1978, 74(1):38-43.
    • (1978) Gastroenterology , vol.74 , Issue.1 , pp. 38-43
    • Green, F.W.1    Kaplan, M.M.2    Curtis, L.E.3    Levine, P.H.4
  • 51
    • 0018887062 scopus 로고
    • Fibrinolytic activity of gastroduodenal secretions - a possible role in upper gastrointestinal haemorrhage
    • Low J., Dodds A.J., Biggs J.C. Fibrinolytic activity of gastroduodenal secretions - a possible role in upper gastrointestinal haemorrhage. Thromb Res. 1980, 17(6):819-830.
    • (1980) Thromb Res. , vol.17 , Issue.6 , pp. 819-830
    • Low, J.1    Dodds, A.J.2    Biggs, J.C.3
  • 52
    • 0026803020 scopus 로고
    • Appropriate acid suppression for the management of gastro-oesophageal reflux disease
    • Bell N.J., Burget D., Howden C.W., Wilkinson J., Hunt R.H. Appropriate acid suppression for the management of gastro-oesophageal reflux disease. Digestion 1992, 51(Suppl. 1):59-67.
    • (1992) Digestion , vol.51 , Issue.SUPPL. 1 , pp. 59-67
    • Bell, N.J.1    Burget, D.2    Howden, C.W.3    Wilkinson, J.4    Hunt, R.H.5
  • 53
    • 0034960057 scopus 로고    scopus 로고
    • Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician
    • Huang J.Q., Hunt R.H. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician. Best Pract Res Clin Gastroenterol 2001, 15(3):355-370.
    • (2001) Best Pract Res Clin Gastroenterol , vol.15 , Issue.3 , pp. 355-370
    • Huang, J.Q.1    Hunt, R.H.2
  • 54
    • 0024214265 scopus 로고
    • Relationship between reduction of gastric acid secretion and plasma gastrin concentration during omeprazole treatment
    • Lind T., Cederberg C., Forssell H., Olausson M., Olbe L. Relationship between reduction of gastric acid secretion and plasma gastrin concentration during omeprazole treatment. Scand J Gastroenterol 1988, 23(10):1259-1266.
    • (1988) Scand J Gastroenterol , vol.23 , Issue.10 , pp. 1259-1266
    • Lind, T.1    Cederberg, C.2    Forssell, H.3    Olausson, M.4    Olbe, L.5
  • 55
    • 0024469464 scopus 로고
    • Effect of omeprazole on gastric acid secretion and plasma gastrin in man
    • Olbe L., Cederberg C., Lind T., Olausson M. Effect of omeprazole on gastric acid secretion and plasma gastrin in man. Scand J Gastroenterol Suppl 1989, 166:27-32.
    • (1989) Scand J Gastroenterol Suppl , vol.166 , pp. 27-32
    • Olbe, L.1    Cederberg, C.2    Lind, T.3    Olausson, M.4
  • 56
    • 0029861304 scopus 로고    scopus 로고
    • Omeprazole produces parietal cell hypertrophy and hyperplasia in humans
    • Driman D.K., Wright C., Tougas G., Riddell R.H. Omeprazole produces parietal cell hypertrophy and hyperplasia in humans. Dig Dis Sci. 1996, 41(10):2039-2047.
    • (1996) Dig Dis Sci. , vol.41 , Issue.10 , pp. 2039-2047
    • Driman, D.K.1    Wright, C.2    Tougas, G.3    Riddell, R.H.4
  • 57
    • 0025857311 scopus 로고
    • Nocturnal intragastric acidity during and after a period of dosing with either ranitidine or omeprazole
    • Prewett E.J., Hudson M., Nwokolo C.U., Sawyerr A.M., Pounder R.E. Nocturnal intragastric acidity during and after a period of dosing with either ranitidine or omeprazole. Gastroenterology 1991, 100(4):873-877.
    • (1991) Gastroenterology , vol.100 , Issue.4 , pp. 873-877
    • Prewett, E.J.1    Hudson, M.2    Nwokolo, C.U.3    Sawyerr, A.M.4    Pounder, R.E.5
  • 58
    • 0025297988 scopus 로고
    • Self-replication of enterochromaffin-like cells in the mouse stomach
    • Tielemans Y., Willems G., Sundler F., Håkanson R. Self-replication of enterochromaffin-like cells in the mouse stomach. Digestion 1990, 45(3):138-146.
    • (1990) Digestion , vol.45 , Issue.3 , pp. 138-146
    • Tielemans, Y.1    Willems, G.2    Sundler, F.3    Håkanson, R.4
  • 59
    • 0027158050 scopus 로고
    • Enterochromaffin-like (ECL) cells and their growths: relationships to gastrin, reduced acid secretion and gastritis
    • Solcia E., Rindi G., Silini E., Villani L. Enterochromaffin-like (ECL) cells and their growths: relationships to gastrin, reduced acid secretion and gastritis. Baillieres Clin Gastroenterol. 1993, 7(1):149-165.
    • (1993) Baillieres Clin Gastroenterol. , vol.7 , Issue.1 , pp. 149-165
    • Solcia, E.1    Rindi, G.2    Silini, E.3    Villani, L.4
  • 60
    • 0028596965 scopus 로고
    • ECL cells: biology and pathobiology
    • Håkanson R., Chen D., Tielemans Y., et al. ECL cells: biology and pathobiology. Digestion 1994, 55(Suppl. 3):38-45.
    • (1994) Digestion , vol.55 , Issue.SUPPL. 3 , pp. 38-45
    • Håkanson, R.1    Chen, D.2    Tielemans, Y.3
  • 61
    • 0030468499 scopus 로고    scopus 로고
    • Marked increase in gastric acid secretory capacity after omeprazole treatment
    • Waldum H.L., Arnestad J.S., Brenna E., Eide I., Syversen U., Sandvik A.K. Marked increase in gastric acid secretory capacity after omeprazole treatment. Gut 1996, 39(5):649-653.
    • (1996) Gut , vol.39 , Issue.5 , pp. 649-653
    • Waldum, H.L.1    Arnestad, J.S.2    Brenna, E.3    Eide, I.4    Syversen, U.5    Sandvik, A.K.6
  • 62
    • 0032924619 scopus 로고    scopus 로고
    • Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status
    • Gillen D., Wirz A.A., Ardill J.E., McColl K.E. Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status. Gastroenterology 1999, 116(2):239-247.
    • (1999) Gastroenterology , vol.116 , Issue.2 , pp. 239-247
    • Gillen, D.1    Wirz, A.A.2    Ardill, J.E.3    McColl, K.E.4
  • 63
    • 1842583753 scopus 로고    scopus 로고
    • Helicobacter pylori eradication releases prolonged increased acid secretion following omeprazole treatment
    • Gillen D., Wirz A.A., McColl K.E. Helicobacter pylori eradication releases prolonged increased acid secretion following omeprazole treatment. Gastroenterology 2004, 126(4):980-988.
    • (2004) Gastroenterology , vol.126 , Issue.4 , pp. 980-988
    • Gillen, D.1    Wirz, A.A.2    McColl, K.E.3
  • 64
    • 13544270995 scopus 로고    scopus 로고
    • Rebound acid hypersecretion after long-term inhibition of gastric acid secretion
    • Fossmark R., Johnsen G., Johanessen E., Waldum H.L. Rebound acid hypersecretion after long-term inhibition of gastric acid secretion. Aliment Pharmacol Ther 2005, 21(2):149-154.
    • (2005) Aliment Pharmacol Ther , vol.21 , Issue.2 , pp. 149-154
    • Fossmark, R.1    Johnsen, G.2    Johanessen, E.3    Waldum, H.L.4
  • 65
    • 0031898903 scopus 로고    scopus 로고
    • Eradicating Helicobacter pylori reduces hypergastrinaemia during long-term omeprazole treatment
    • el-Nujumi A., Williams C., Ardill J.E., Oien K., McColl K.E. Eradicating Helicobacter pylori reduces hypergastrinaemia during long-term omeprazole treatment. Gut 1998, 42(2):159-165.
    • (1998) Gut , vol.42 , Issue.2 , pp. 159-165
    • el-Nujumi, A.1    Williams, C.2    Ardill, J.E.3    Oien, K.4    McColl, K.E.5
  • 66
    • 0026670402 scopus 로고
    • Trophic effect of gastrin on the enterochromaffin like cells of the rat stomach: establishment of a dose response relationship
    • Brenna E., Waldum H.L. Trophic effect of gastrin on the enterochromaffin like cells of the rat stomach: establishment of a dose response relationship. Gut 1992, 33(10):1303-1306.
    • (1992) Gut , vol.33 , Issue.10 , pp. 1303-1306
    • Brenna, E.1    Waldum, H.L.2
  • 67
    • 0025941501 scopus 로고
    • Secretagogue-specific effects of interleukin-1 on gastric acid secretion
    • Wallace J.L., Cucala M., Mugridge K., Parente L. Secretagogue-specific effects of interleukin-1 on gastric acid secretion. Am J Physiol 1991, 261(4 Pt 1):G559-G564.
    • (1991) Am J Physiol , vol.261 , Issue.4 PART 1
    • Wallace, J.L.1    Cucala, M.2    Mugridge, K.3    Parente, L.4
  • 68
    • 0027056713 scopus 로고
    • Potent inhibition of gastric acid secretion and ulcer formation by centrally and peripherally administered interleukin-1
    • Taché Y., Saperas E. Potent inhibition of gastric acid secretion and ulcer formation by centrally and peripherally administered interleukin-1. Ann N Y Acad Sci. 1992, 664:353-368.
    • (1992) Ann N Y Acad Sci. , vol.664 , pp. 353-368
    • Taché, Y.1    Saperas, E.2
  • 69
    • 0029146892 scopus 로고
    • Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety
    • Kuipers E.J., Uyterlinde A.M., Peña A.S., et al. Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety. Am J Gastroenterol 1995, 90(9):1401-1406.
    • (1995) Am J Gastroenterol , vol.90 , Issue.9 , pp. 1401-1406
    • Kuipers, E.J.1    Uyterlinde, A.M.2    Peña, A.S.3
  • 70
    • 0030927818 scopus 로고    scopus 로고
    • Helicobacter pylori infection and chronic gastric acid hyposecretion
    • El-Omar E.M., Oien K., El-Nujumi A., et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 1997, 113(1):15-24.
    • (1997) Gastroenterology , vol.113 , Issue.1 , pp. 15-24
    • El-Omar, E.M.1    Oien, K.2    El-Nujumi, A.3
  • 71
    • 0031056626 scopus 로고    scopus 로고
    • Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia
    • Eissele R., Brunner G., Simon B., Solcia E., Arnold R. Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia. Gastroenterology 1997, 112(3):707-717.
    • (1997) Gastroenterology , vol.112 , Issue.3 , pp. 707-717
    • Eissele, R.1    Brunner, G.2    Simon, B.3    Solcia, E.4    Arnold, R.5
  • 72
  • 73
    • 0025060125 scopus 로고
    • Campylobacter pylori: its link to gastritis and peptic ulcer disease
    • Marshall B.J. Campylobacter pylori: its link to gastritis and peptic ulcer disease. Rev Infect Dis 1990, 12(Suppl. 1):S87-S93.
    • (1990) Rev Infect Dis , vol.12 , Issue.SUPPL. 1
    • Marshall, B.J.1
  • 74
    • 0025371354 scopus 로고
    • Campylobacter pylori and its role in peptic ulcer disease
    • Tytgat G.N., Rauws E.A. Campylobacter pylori and its role in peptic ulcer disease. Gastroenterol Clin North Am 1990, 19(1):183-196.
    • (1990) Gastroenterol Clin North Am , vol.19 , Issue.1 , pp. 183-196
    • Tytgat, G.N.1    Rauws, E.A.2
  • 75
    • 0034064001 scopus 로고    scopus 로고
    • Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa
    • Klinkenberg-Knol E.C., Nelis F., Dent J., et al. Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa. Gastroenterology 2000, 118(4):661-669.
    • (2000) Gastroenterology , vol.118 , Issue.4 , pp. 661-669
    • Klinkenberg-Knol, E.C.1    Nelis, F.2    Dent, J.3
  • 76
    • 77958480781 scopus 로고    scopus 로고
    • Adverse effects of proton pump inhibitor drugs: clues and conclusions
    • McCarthy D.M. Adverse effects of proton pump inhibitor drugs: clues and conclusions. Curr Opin Gastroenterol 2010, 26(6):624-631.
    • (2010) Curr Opin Gastroenterol , vol.26 , Issue.6 , pp. 624-631
    • McCarthy, D.M.1
  • 78
    • 34548566069 scopus 로고    scopus 로고
    • Proton pump inhibitor use and risk of colorectal cancer: a population-based, case-control study
    • Robertson D.J., Larsson H., Friis S., Pedersen L., Baron J.A., Sørensen H.T. Proton pump inhibitor use and risk of colorectal cancer: a population-based, case-control study. Gastroenterology 2007, 133(3):755-760.
    • (2007) Gastroenterology , vol.133 , Issue.3 , pp. 755-760
    • Robertson, D.J.1    Larsson, H.2    Friis, S.3    Pedersen, L.4    Baron, J.A.5    Sørensen, H.T.6
  • 79
    • 0033612855 scopus 로고    scopus 로고
    • Heartburn treatment in primary care: randomised, double blind study for 8 weeks
    • Hatlebakk J.G., Hyggen A., Madsen P.H., et al. Heartburn treatment in primary care: randomised, double blind study for 8 weeks. BMJ 1999, 319(7209):550-553.
    • (1999) BMJ , vol.319 , Issue.7209 , pp. 550-553
    • Hatlebakk, J.G.1    Hyggen, A.2    Madsen, P.H.3
  • 80
    • 0347357637 scopus 로고    scopus 로고
    • Rising incidence of reflux oesophagitis in patients undergoing upper gastrointestinal endoscopy
    • Loffeld R.J., van der Putten A.B. Rising incidence of reflux oesophagitis in patients undergoing upper gastrointestinal endoscopy. Digestion 2003, 68(2-3):141-144.
    • (2003) Digestion , vol.68 , Issue.2-3 , pp. 141-144
    • Loffeld, R.J.1    van der Putten, A.B.2
  • 81
    • 77951977553 scopus 로고    scopus 로고
    • Elevated serum gastrin is associated with a history of advanced neoplasia in Barrett's esophagus
    • Wang J.S., Varro A., Lightdale C.J., et al. Elevated serum gastrin is associated with a history of advanced neoplasia in Barrett's esophagus. Am J Gastroenterol 2010, 105(5):1039-1045.
    • (2010) Am J Gastroenterol , vol.105 , Issue.5 , pp. 1039-1045
    • Wang, J.S.1    Varro, A.2    Lightdale, C.J.3
  • 82
    • 0033960131 scopus 로고    scopus 로고
    • Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer
    • Wang T.C., Dangler C.A., Chen D., et al. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology 2000, 118(1):36-47.
    • (2000) Gastroenterology , vol.118 , Issue.1 , pp. 36-47
    • Wang, T.C.1    Dangler, C.A.2    Chen, D.3
  • 83
    • 21844434191 scopus 로고    scopus 로고
    • Dedifferentiation of enterochromaffin-like cells in gastric cancer of hypergastrinemic cotton rats
    • Fossmark R., Zhao C.M., Martinsen T.C., Kawase S., Chen D., Waldum H.L. Dedifferentiation of enterochromaffin-like cells in gastric cancer of hypergastrinemic cotton rats. APMIS 2005, 113(6):436-449.
    • (2005) APMIS , vol.113 , Issue.6 , pp. 436-449
    • Fossmark, R.1    Zhao, C.M.2    Martinsen, T.C.3    Kawase, S.4    Chen, D.5    Waldum, H.L.6
  • 84
    • 59249095362 scopus 로고    scopus 로고
    • Importance of gastrin in the pathogenesis and treatment of gastric tumors
    • Burkitt M.D., Varro A., Pritchard D.M. Importance of gastrin in the pathogenesis and treatment of gastric tumors. World J Gastroenterol 2009, 15(1):1-16.
    • (2009) World J Gastroenterol , vol.15 , Issue.1 , pp. 1-16
    • Burkitt, M.D.1    Varro, A.2    Pritchard, D.M.3
  • 85
    • 65549096192 scopus 로고    scopus 로고
    • Proton pump inhibitors and risk of gastric cancer: a population-based cohort study
    • Poulsen A.H., Christensen S., McLaughlin J.K., et al. Proton pump inhibitors and risk of gastric cancer: a population-based cohort study. Br J Cancer 2009, 100(9):1503-1507.
    • (2009) Br J Cancer , vol.100 , Issue.9 , pp. 1503-1507
    • Poulsen, A.H.1    Christensen, S.2    McLaughlin, J.K.3
  • 87
    • 0025017370 scopus 로고
    • Trophic effects of continuous infusion of [Leu15]-gastrin-17 in the rat
    • Ryberg B., Axelson J., Håkanson R., Sundler F., Mattsson H. Trophic effects of continuous infusion of [Leu15]-gastrin-17 in the rat. Gastroenterology 1990, 98(1):33-38.
    • (1990) Gastroenterology , vol.98 , Issue.1 , pp. 33-38
    • Ryberg, B.1    Axelson, J.2    Håkanson, R.3    Sundler, F.4    Mattsson, H.5
  • 88
    • 1542388403 scopus 로고    scopus 로고
    • 50-year analysis of 562 gastric carcinoids: small tumor or larger problem?
    • Modlin I.M., Lye K.D., Kidd M.A. 50-year analysis of 562 gastric carcinoids: small tumor or larger problem?. Am J Gastroenterol 2004, 99(1):23-32.
    • (2004) Am J Gastroenterol , vol.99 , Issue.1 , pp. 23-32
    • Modlin, I.M.1    Lye, K.D.2    Kidd, M.A.3
  • 89
    • 28344431724 scopus 로고    scopus 로고
    • Gastric carcinoids: a temporal increase with proton pump introduction
    • Hodgson N., Koniaris L.G., Livingstone A.S., Franceschi D. Gastric carcinoids: a temporal increase with proton pump introduction. Surg Endosc 2005, 19(12):1610-1612.
    • (2005) Surg Endosc , vol.19 , Issue.12 , pp. 1610-1612
    • Hodgson, N.1    Koniaris, L.G.2    Livingstone, A.S.3    Franceschi, D.4
  • 91
    • 33845388064 scopus 로고    scopus 로고
    • Systematic review: rebound acid hypersecretion after therapy with proton pump inhibitors
    • Hunfeld N.G., Geus W.P., Kuipers E.J. Systematic review: rebound acid hypersecretion after therapy with proton pump inhibitors. Aliment Pharmacol Ther 2007, 25(1):39-46.
    • (2007) Aliment Pharmacol Ther , vol.25 , Issue.1 , pp. 39-46
    • Hunfeld, N.G.1    Geus, W.P.2    Kuipers, E.J.3
  • 92
  • 93
    • 67649222366 scopus 로고    scopus 로고
    • Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy
    • Reimer C., Søndergaard B., Hilsted L., Bytzer P. Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy. Gastroenterology 2009, 137(1):80-87.
    • (2009) Gastroenterology , vol.137 , Issue.1 , pp. 80-87
    • Reimer, C.1    Søndergaard, B.2    Hilsted, L.3    Bytzer, P.4
  • 94
    • 77954424083 scopus 로고    scopus 로고
    • Dyspeptic symptom development after discontinuation of a proton pump inhibitor: a double-blind placebo-controlled trial
    • Niklasson A., Lindström L., Simrén M., Lindberg G., Björnsson E. Dyspeptic symptom development after discontinuation of a proton pump inhibitor: a double-blind placebo-controlled trial. Am J Gastroenterol 2010, 105(7):1531-1537.
    • (2010) Am J Gastroenterol , vol.105 , Issue.7 , pp. 1531-1537
    • Niklasson, A.1    Lindström, L.2    Simrén, M.3    Lindberg, G.4    Björnsson, E.5
  • 95
    • 33748320795 scopus 로고    scopus 로고
    • Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial
    • Björnsson E., Abrahamsson H., Simrén M., et al. Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial. Aliment Pharmacol Ther 2006, 24(6):945-954.
    • (2006) Aliment Pharmacol Ther , vol.24 , Issue.6 , pp. 945-954
    • Björnsson, E.1    Abrahamsson, H.2    Simrén, M.3
  • 96
    • 77957582373 scopus 로고    scopus 로고
    • Discontinuation of long-term proton pump inhibitor therapy in primary care patients: a randomized placebo-controlled trial in patients with symptom relapse
    • Reimer C., Bytzer P. Discontinuation of long-term proton pump inhibitor therapy in primary care patients: a randomized placebo-controlled trial in patients with symptom relapse. Eur J Gastroenterol Hepatol 2010, 22(10):1182-1188.
    • (2010) Eur J Gastroenterol Hepatol , vol.22 , Issue.10 , pp. 1182-1188
    • Reimer, C.1    Bytzer, P.2
  • 97
    • 0032529474 scopus 로고    scopus 로고
    • Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database
    • Bashford J.N., Norwood J., Chapman S.R. Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database. BMJ 1998, 317(7156):452-456.
    • (1998) BMJ , vol.317 , Issue.7156 , pp. 452-456
    • Bashford, J.N.1    Norwood, J.2    Chapman, S.R.3
  • 98
    • 0033755629 scopus 로고    scopus 로고
    • Overuse of acid-suppressive therapy in hospitalized patients
    • Nardino R.J., Vender R.J., Herbert P.N. Overuse of acid-suppressive therapy in hospitalized patients. Am J Gastroenterol 2000, 95(11):3118-3122.
    • (2000) Am J Gastroenterol , vol.95 , Issue.11 , pp. 3118-3122
    • Nardino, R.J.1    Vender, R.J.2    Herbert, P.N.3
  • 99
    • 0034598374 scopus 로고    scopus 로고
    • Concordance between use of proton pump inhibitors and prescribing guidelines
    • Pillans P.I., Kubler P.A., Radford J.M., Overland V. Concordance between use of proton pump inhibitors and prescribing guidelines. Med J Aust 2000, 172(1):16-18.
    • (2000) Med J Aust , vol.172 , Issue.1 , pp. 16-18
    • Pillans, P.I.1    Kubler, P.A.2    Radford, J.M.3    Overland, V.4
  • 100
    • 23844437282 scopus 로고    scopus 로고
    • Review article: the long-term use of proton-pump inhibitors
    • Raghunath A.S., O'Morain C., McLoughlin R.C. Review article: the long-term use of proton-pump inhibitors. Aliment Pharmacol Ther 2005, 22(Suppl. 1):55-63.
    • (2005) Aliment Pharmacol Ther , vol.22 , Issue.SUPPL. 1 , pp. 55-63
    • Raghunath, A.S.1    O'Morain, C.2    McLoughlin, R.C.3
  • 101
    • 38149126506 scopus 로고    scopus 로고
    • Overprescribing proton pump inhibitors
    • Forgacs I., Loganayagam A. Overprescribing proton pump inhibitors. BMJ 2008, 336(7634):2-3.
    • (2008) BMJ , vol.336 , Issue.7634 , pp. 2-3
    • Forgacs, I.1    Loganayagam, A.2
  • 103
    • 79251491014 scopus 로고    scopus 로고
    • Marked increase in proton pump inhibitors use in Australia
    • Hollingworth S., Duncan E.L., Martin J.H. Marked increase in proton pump inhibitors use in Australia. Pharmacoepidemiol Drug Saf 2010, 19(10):1019-1024.
    • (2010) Pharmacoepidemiol Drug Saf , vol.19 , Issue.10 , pp. 1019-1024
    • Hollingworth, S.1    Duncan, E.L.2    Martin, J.H.3
  • 105
    • 69949152539 scopus 로고    scopus 로고
    • Clinical trial: long-term use of proton pump inhibitors in primary care patients - a cross sectional analysis of 901 patients
    • Reimer C., Bytzer P. Clinical trial: long-term use of proton pump inhibitors in primary care patients - a cross sectional analysis of 901 patients. Aliment Pharmacol Ther 2009, 30(7):725-732.
    • (2009) Aliment Pharmacol Ther , vol.30 , Issue.7 , pp. 725-732
    • Reimer, C.1    Bytzer, P.2
  • 107
    • 27744571011 scopus 로고    scopus 로고
    • Practice Parameters Committee of the American College of Gastroenterology. Guidelines for the management of dyspepsia
    • Talley N.J., Vakil N. Practice Parameters Committee of the American College of Gastroenterology. Guidelines for the management of dyspepsia. Am J Gastroenterol 2005, 100(10):2324-2337.
    • (2005) Am J Gastroenterol , vol.100 , Issue.10 , pp. 2324-2337
    • Talley, N.J.1    Vakil, N.2
  • 108
    • 38349165398 scopus 로고    scopus 로고
    • A second-order simulation model of the cost-effectiveness of managing dyspepsia in the United States
    • Barton P.M., Moayyedi P., Talley N.J., Vakil N.B., Delaney B.C. A second-order simulation model of the cost-effectiveness of managing dyspepsia in the United States. Med Decis Making 2008, 28(1):44-55.
    • (2008) Med Decis Making , vol.28 , Issue.1 , pp. 44-55
    • Barton, P.M.1    Moayyedi, P.2    Talley, N.J.3    Vakil, N.B.4    Delaney, B.C.5
  • 110
    • 0042358904 scopus 로고    scopus 로고
    • [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios]
    • Limmer S., Ittel T.H., Wietholtz H. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios]. Z Gastroenterol 2003, 41(8):719-728.
    • (2003) Z Gastroenterol , vol.41 , Issue.8 , pp. 719-728
    • Limmer, S.1    Ittel, T.H.2    Wietholtz, H.3
  • 111
    • 33846572930 scopus 로고    scopus 로고
    • [Validity of proton pump inhibitors' prescriptions in a department of internal medicine]
    • Marie I., Moutot A., Tharrasse A., et al. [Validity of proton pump inhibitors' prescriptions in a department of internal medicine]. Rev Med Interne 2007, 28(2):86-93.
    • (2007) Rev Med Interne , vol.28 , Issue.2 , pp. 86-93
    • Marie, I.1    Moutot, A.2    Tharrasse, A.3
  • 113
    • 74249102181 scopus 로고    scopus 로고
    • Do proton pump inhibitors attenuate the effect of aspirin on platelet aggregation? A randomized crossover study
    • Adamopoulos A.B., Sakizlis G.N., Nasothimiou E.G., et al. Do proton pump inhibitors attenuate the effect of aspirin on platelet aggregation? A randomized crossover study. J Cardiovasc Pharmacol 2009, 54(2):163-168.
    • (2009) J Cardiovasc Pharmacol , vol.54 , Issue.2 , pp. 163-168
    • Adamopoulos, A.B.1    Sakizlis, G.N.2    Nasothimiou, E.G.3
  • 115
    • 67649217255 scopus 로고    scopus 로고
    • Evidence that proton-pump inhibitor therapy induces the symptoms it is used to treat
    • McColl K.E., Gillen D. Evidence that proton-pump inhibitor therapy induces the symptoms it is used to treat. Gastroenterology 2009, 137(1):20-22.
    • (2009) Gastroenterology , vol.137 , Issue.1 , pp. 20-22
    • McColl, K.E.1    Gillen, D.2
  • 116
    • 0003392747 scopus 로고
    • American Society of Hospital Pharmacists, Bethesda
    • American Hospital Formulary Service Drug Information 1990, American Society of Hospital Pharmacists, Bethesda, pp. 1667-1668.
    • (1990) American Hospital Formulary Service Drug Information , pp. 1667-1668
  • 117
    • 0037322551 scopus 로고    scopus 로고
    • Homeopathic use of modern medicines: utilisation of the curative rebound effect
    • Teixeira M.Z. Homeopathic use of modern medicines: utilisation of the curative rebound effect. Med Hypotheses 2003, 60(2):276-283.
    • (2003) Med Hypotheses , vol.60 , Issue.2 , pp. 276-283
    • Teixeira, M.Z.1
  • 118
    • 26844560879 scopus 로고    scopus 로고
    • 'Paradoxical strategy for treating chronic diseases': a therapeutic model used in homeopathy for more than two centuries
    • Teixeira M.Z. 'Paradoxical strategy for treating chronic diseases': a therapeutic model used in homeopathy for more than two centuries. Homeopathy 2005, 94(4):265-266.
    • (2005) Homeopathy , vol.94 , Issue.4 , pp. 265-266
    • Teixeira, M.Z.1
  • 119
    • 79960626362 scopus 로고    scopus 로고
    • New homeopathic medicines: use of modern drugs according to the principle of similitude
    • doi:10.1016/j.homp.2011.01.002
    • Teixeira M.Z. New homeopathic medicines: use of modern drugs according to the principle of similitude. Homeopathy 2011, doi:10.1016/j.homp.2011.01.002.
    • (2011) Homeopathy
    • Teixeira, M.Z.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.